Innate Pharma S.A.

IPH.PA | EURONEXT | 0 Sledující

€1.98

-0.10%

-€0.0020

Sledovat

Overview Metrics Financials

Breakdown	12/31/2024 EUR	12/31/2023 EUR	12/31/2022 EUR	12/31/2021 EUR
Total revenue	12,622 -75.68%	51,901 +4.56%	49,639 +309.83%	12,112 -
Cost of revenue	12,622 -77.47%	56,022 +8.44%	51,663 +9.91%	47,004 -
Gross profit	0 +100.00%	-4,121 -103.61%	-2,024 +94.20%	-34,892 -
Operating expense	69,702 +7.95%	64,570 -2.26%	66,064 +10.22%	59,937 -
Operating income	-59,074 -366.29%	-12,669 -8.74%	-11,651 +75.64%	-47,825 -
Pretax Income	-56,959 -652.43%	-7,570 +86.94%	-57,972 -27.47%	-45,478 -
Tax Provision	-7,488 -	0 -100.00%	41,131 +201.15%	13,658 -
Net income	-49,471 -553.51%	-7,570 +92.36%	-99,103 -67.58%	-59,136 -
EPS	-0.61 -548.25%	-0.09 +92.41%	-1.24 -67.57%	-0.74 -
Diluted EPS	-0.61 -548.25%	-0.09 +92.41%	-1.24 -67.57%	-0.74 -
Average Shares	81,052 +0.74%	80,453 +1.02%	79,640 +0.12%	79,543 -
Diluted Average Shares	81,052 +0.74%	80,453 +1.02%	79,640 +0.12%	79,543 -
EBIT	-52,984 -664.56%	-6,930 +87.99%	-57,684 -27.72%	-45,166 -
EBITDA	-50,990 -572.87%	-7,578 +87.64%	-61,295 -41.79%	-43,229 -

Soubory cookie používáme ke zlepšení prohlížení na webu.